NCT00066651已完成1 期
Phase I Study Of SS1(dsFv)-PE38 Anti-Mesothelin Immunotoxin In Advanced Malignancies: I.V. Infusion QOD Dosing
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 试验地点
- 4
研究概览
简要总结
RATIONALE: Immunotoxins can locate tumor cells and kill them without harming normal cells. Immunotoxin therapy may be effective in treating advanced solid tumors.
PURPOSE: This phase I trial is studying the side effects and best dose of immunotoxin therapy in treating patients with recurrent unresectable advanced solid tumors.
详细描述
OBJECTIVES:
Primary
- Determine the maximum tolerated dose of SS1(dsFv)-PE38 immunotoxin in patients with advanced mesothelin-expressing malignancies.
Secondary
- Determine the toxic effects of this drug in these patients.
- Determine the plasma pharmacokinetics of this drug in these patients.
- Determine the response in patients treated with this drug.
- Correlate the induction of antibody against this drug with its pharmacokinetics in these patients.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (4)
Loading locations...
相似试验
已完成
1 期
Immunotoxin Therapy in Treating Patients With Advanced CancerFallopian Tube CancerHead and Neck CancerMalignant MesotheliomaPrimary Peritoneal Cavity CancerLung CancerOvarian CancerPancreatic CancerCervical CancerNCT00006981National Cancer Institute (NCI)
已完成
1 期
Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant GliomaBrain and Central Nervous System TumorsNCT00036972Memorial Sloan Kettering Cancer Center
已完成
1 期
Immunotoxin in Treating Patients With Leukemia or LymphomaLymphomaLeukemiaNCT00002765National Cancer Institute (NCI)
已完成
1 期
Mesothelin-Targeted Immunotoxin LMB-100 in Combination With Tofacitinib in Persons With Previously Treated Pancreatic Adenocarcinoma, Cholangiocarcinoma and Other Mesothelin Expressing Solid TumorsNeoplasms With Mesothelin ExpressionEpithelioid MesotheliomaCholangiocarcinoma, ExtrahepaticAdenocarcinoma, PancreaticNCT04034238National Cancer Institute (NCI)19
撤回
1 期
Immunotoxin Therapy in Treating Children With Recurrent Malignant GliomasBrain and Central Nervous System TumorsNCT00053040Pediatric Brain Tumor Consortium